TY  - GEN
AU  - Brachman,David G
AU  - Pugh,Stephanie L
AU  - Ashby,Lynn S
AU  - Thomas,Theresa A
AU  - Dunbar,Erin M
AU  - Narayan,Samir
AU  - Robins,H Ian
AU  - Bovi,Joseph A
AU  - Rockhill,Jason K
AU  - Won,Minhee
AU  - Curran,Walter P
TI  - Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513
SN  - 1879-355X
PY  - 2015///0603
KW  - Antineoplastic Agents, Alkylating
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Brain Neoplasms
KW  - mortality
KW  - Chemoradiotherapy
KW  - adverse effects
KW  - Dacarbazine
KW  - Disease-Free Survival
KW  - Dose Fractionation, Radiation
KW  - Female
KW  - Glioblastoma
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Metalloporphyrins
KW  - Multivariate Analysis
KW  - Supratentorial Neoplasms
KW  - Temozolomide
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1016/j.ijrobp.2014.12.050
ER  -